Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ALX Oncology Holdings Inc. - Common Stock (NQ:ALXO)

1.630 +0.130 (+8.67%)
Streaming Delayed Price Updated: 10:57 AM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ALX Oncology Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
From ALX Oncology
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
ALX Oncology Holdings's Earnings: A Preview
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
What's Next: ALX Oncology Holdings's Earnings Preview
 
Via Benzinga
Which stocks are gapping on Friday?
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer
From ALX Oncology
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
ALX Oncology to Participate in Upcoming Investor Conferences in September
From ALX Oncology
Via GlobeNewswire
Unusual volume stocks in Friday's session
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
Tuesday's pre-market session: top gainers and losers
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
ALX Oncology Doses First Patient in Phase 1 Dose Escalation Trial Evaluating ADC ALX2004 for the Treatment of EGFR-Expressing Solid Tumors
From ALX Oncology
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday?
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
What's going on in today's session
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
ALX Oncology Holdings Inc (NASDAQ:ALXO) Reports Q2 2025 Results with Wider Loss but Strong Clinical Progress
ALX Oncology reports Q2 2025 results with a net loss of $25.9M, wider than expected, but shares dip only slightly. Clinical progress, including evorpacept data and ALX2004 trials, remains key focus.... 
Via Chartmill
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From ALX Oncology
Via GlobeNewswire
Earnings Scheduled For August 12, 2025
 
Via Benzinga
ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025
From ALX Oncology
Via GlobeNewswire
Top movers in Tuesday's after hours session
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference
From ALX Oncology
Via GlobeNewswire
ALX Oncology Highlights Differentiated Design, Preclinical Data and Development Plans for EGFR-Targeted ADC, ALX2004, in R&D Webcast Event
From ALX Oncology
Via GlobeNewswire
ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
From ALX Oncology
Via GlobeNewswire
ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
From ALX Oncology
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.